-
Sector Analysis
Electrical Activity Testing Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Electrical Activity Testing Market Report Overview The electrical activity testing market was valued at $1.31 billion in 2023 and will grow at a CAGR of more than 1% from 2023 to 2033. Neurodiagnostic tests are used to diagnose suspected neurological disorders through EEG, MEG, or EMG by looking at brain activity. One of the key drivers of EEG and EMG markets is the increase in the aging population. This sector of the population is prone to developing neurological disorders, such...
-
Product Insights
NewCutaneous Mycosis – Drugs In Development, 2024
Empower your strategies with our Cutaneous Mycosis – Drugs In Development, 2024 report and make more profitable business decisions. Cutaneous mycoses are a group of superficial fungal infections that affect the skin, hair, and nails. They are also known as superficial mycoses. They are confined to the outer layers of the skin, hair, or nails. They rarely invade deeper tissues or viscera, and do not induce a cellular response from the host. Most cutaneous mycoses are caused by dermatophytes, a group...
-
Product Insights
NewStomatitis (Sore Mouth) – Drugs In Development, 2024
Empower your strategies with our Stomatitis (Sore Mouth) – Drugs In Development, 2024 report and make more profitable business decisions. Stomatitis is inflammation of the mouth and lips. It refers to any inflammatory process affecting the mucous membranes of the mouth and lips, with or without oral ulceration. The inflammation can be the result of conditions within the mouth itself, such as poor oral hygiene, poorly fitted dentures, or mouth burns from hot food or drinks. It may also be caused...
-
Product Insights
NewOral Mucositis – Drugs In Development, 2024
Empower your strategies with our Oral Mucositis – Drugs In Development, 2024 report and make more profitable business decisions. Oral mucositis is the most common type of mucositis. It is a debilitating complication of cancer surgery, chemotherapy, and radiation. Symptoms include change in mucosa color, hyposalivation, a change in the integrity of the mucosa, and the presence of edema on the lips and/or the tongue. Treatment includes oral decontamination (mouth care) and oral debridement. The Oral Mucositis drugs in development market...
-
Product Insights
NewOnychomycosis (Tinea Unguium) – Drugs In Development, 2024
Empower your strategies with our Onychomycosis (Tinea Unguium) – Drugs In Development, 2024 report and make more profitable business decisions. Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail, and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and surgery. The Onychomycosis (Tinea Unguium) drugs in development market research report provide comprehensive information on the therapeutics...
-
Product Insights
NewMycoses – Drugs In Development, 2024
Empower your strategies with our Mycoses – Drugs In Development, 2024 report and make more profitable business decisions. Mycoses, also known as fungal infections, encompass a diverse group of diseases caused by fungi. These infections can affect various tissues in the body, including the skin, nails, and internal organs. Superficial mycoses, like athlete's foot and ringworm, involve the outer layers, while systemic mycoses can affect deeper tissues and may be more severe, particularly in individuals with weakened immune systems. Candidiasis is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ibrutinib in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug Details: Ibrutinib (Imbruvica) is an anti-neoplastic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Terbinafine Hydrochloride in Onychomycosis (Tinea Unguium)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Terbinafine Hydrochloride in Onychomycosis (Tinea Unguium) report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Aminolevulinic Acid Hydrochloride in Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Aminolevulinic Acid Hydrochloride in Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Aminolevulinic Acid Hydrochloride in Anemia Drug Details:Aminolevulinic acid hydrochloride (5-ALA) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bupivacaine Hydrochloride in Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bupivacaine Hydrochloride in Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Bupivacaine Hydrochloride in Oral MucositisDrug Details:Bupivacaine hydrochloride is under development for the...